This grant project ended March 31, 2009.
The Attorney General Consumer and Prescriber Education Grant Program (CPGP) was created to educate health care professionals about pharmaceutical industry marketing practices and to provide tools for accessing unbiased sources of information about prescription drugs. The program is funded through the 2004 Attorneys General settlement resolving allegations that Warner Lambert violated state consumer protection laws when promoting Neurontin, an epilepsy drug, for off-label uses.
The Office for Oregon Health Policy and Research (OHPR) collaborated with the Oregon State University College of Pharmacy to develop a curriculum to educate healthcare professionals to critically view pharmaceutical marketing strategies and to access unbiased evidence-based drug comparisons to encourage quality and cost-effective prescribing.
Online courses were available free of charge to licensed medical prescribers in the nation and offered continuing medical education credit:
Using Evidence to Guide Drug Therapy Decisions
Critical Appraisal: Randomized-Controlled Trials for Drug Therapy
Critical Appraisal: Systematic Reviews and Clinical Practice Guidelines for Drug Therapy
Pharmaceutical Industry Marketing and Influence
Recognizing Pharmaceutical Industry Conflicts of Interest
Show Me the Evidence! The Truth about Rx Drugs (PowerPoint version
David Pollack, MD
John Muench, MD
Richard Wopat, MD
Journal of Ethics and Mental Health
April 2009 - 4 (Sept. Suppl.)
Show Me the Evidence: The Ethical Aspects of Pharmaceutical Marketing, Evidence Based Medicine, and Rational Prescribing, David Pollack, MD; Rick Wopat, MD; John Muench, MD, MPH; Daniel M. Hartung, PharmD, MPH
These materials are related to a series of academic detailing sessions conducted at mental health clinics in Oregon in 2007-2008. A report of this activity is forthcoming.
Academic Detailing presentation
Sample profiling form
In addition, a portion of the grant was earmarked for an Oregon Association of Broadcasters (OAB) Public Education Partnership (PEP) through radio and television broadcasting. OHPR developed a consumer-centered communication program that delivers the message of evidence-based research to promote public confidence in lower cost generic drugs and encourage smarter prescription drug purchasing. The Honorable John Kitzhaber, M.D. is the spokesperson for the PSA’s, and each spot is designed to appeal to a certain demographic group. There are three television spots and three radio spots, all close-captioned (TV) and translated into Spanish.
This work was made possible by a grant from the state Attorney General Consumer and Prescriber Education Program which is funded by the multi-state settlement of consumer fraud claims regarding the marketing of the prescription drug Neurontin.